Unlock instant, AI-driven research and patent intelligence for your innovation.

Co-crystal of vitamin D2 and D3, preparation method and use thereof

A vitamin and co-crystal technology, applied in the co-crystal of vitamin D2 and D3 and its preparation field, can solve the problems of poor solubility, unstable amorphous, desolvation, etc., and achieve the effect of prolonging the storage period and good stability

Active Publication Date: 2016-06-01
SHANGHAI INST OF MATERIA MEDICA CHINESE ACAD OF SCI
View PDF1 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

First of all, for solvates, because the types of solvents acceptable in pharmacy are limited, and solvates often undergo desolvation (water) phenomenon during the preparation process, transforming into unstable amorphous or less soluble crystals. type

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Co-crystal of vitamin D2 and D3, preparation method and use thereof
  • Co-crystal of vitamin D2 and D3, preparation method and use thereof
  • Co-crystal of vitamin D2 and D3, preparation method and use thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0040] Vitamin D 2 and D 3 Add it into ethyl acetate according to the stoichiometric ratio of 1:1, after completely dissolving, volatilize slowly to obtain vitamin D 2 with D 3 eutectic.

[0041] Figure 1-3 Example 1 vitamin D is shown respectively 2 with D 3 X-ray powder diffraction (XRPD) pattern, thermogravimetric analysis (TG) pattern and differential scanning calorimetry (DSC) pattern of the eutectic.

Embodiment 2

[0043] Vitamin D 2 and D 3 Add it into acetone according to the stoichiometric ratio of 1:1, after completely dissolving, volatilize slowly to obtain vitamin D 2 with D 3 eutectic.

Embodiment 3

[0045] Vitamin D 2 and D 3 Add it into methanol according to the stoichiometric ratio of 1:1, after completely dissolving, volatilize slowly to obtain vitamin D 2 with D 3 eutectic.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Provided are a vitamin D2 and vitamin D3 eutectic crystal, a preparation method and use thereof, and a pharmaceutical composition comprising the eutectic crystal. The vitamin D2 and vitamin D3 eutectic crystal has the advantages of a high degree of crystallinity and low hygroscopicity and forms a neat crystal type form, and the stability is improved remarkably, so that fabrication processing of medicines and improvement of the physicochemical properties are facilitated and the performance of the prepared medicine is improved.

Description

technical field [0001] The invention belongs to the technical field of medicinal chemistry and crystallization technology, and specifically relates to vitamin D 2 with D 3 The eutectic and its preparation method and use. Background technique [0002] Drug co-crystallization (co-crystal) refers to the interaction between active pharmaceutical ingredient (API) molecules and other physiologically acceptable acids, bases, salts, non-ionic compound molecules through hydrogen bonding, π-π stacking, van der Waals forces and other non-covalent interactions. bonded together in the same crystal lattice. The greatest application value of co-crystals in drugs is that they can introduce new components without changing the covalent structure of drugs, greatly improving the physical and chemical properties of drugs, such as stability, melting point, dissolution rate, dissolution rate, bioavailability, etc. And because there are many types of ligands (CCF), the properties of the drug can...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07C401/00A61K31/593A61P19/08
CPCA61K31/593C07C401/00
Inventor 梅雪锋王建荣朱冰清李莎
Owner SHANGHAI INST OF MATERIA MEDICA CHINESE ACAD OF SCI